This paper is only available as a PDF. To read, Please Download here.
Abstract
Serum gonadotropin, estrogen, and androgen levels were measured in samples obtained
from 19 patients with polycystic ovarian disease (PCO) and from 10 normal women on
day 2 to 4 of their menstrual cycles. In patients with PCO, the mean (±S.E.) concentration
was significantly higher (P < 0.001) than the concentrations found in the normal subjects
for LH (35 ± 4.6 vs. 12.7 ± 2.6 m.I.U. per milliliter), but not for FSH (10.3 ± 0.7
vs. 8.7 ± 0.9 m.I.U. per milliliter). Estrone (E1) levels (92 ± 4 vs. 52 ± 5 pg. per milliliter) were also significantly higher (P
< 0.001), while estradiol (E2) concentrations (58 ± 4 vs. 63 ± 8 pg. per milliliter) were comparable. Testosterone
(T) (468 ± 41 vs. 325 ± 34 pg. per milliliter, P < 0.05), androstenedione (Δ) (2,083
± 138 vs. 1,123 ± 153 pg. per milliliter, P < 0.001), and dehydroepiandrosterone sulfate
(3.4 ± 0.4 vs. 2.0 ± 0.37 μg per milliliter, P < 0.02) were also significantly increased
over the values in normal controls. The mean dehydroepiandrosterone (DHEA) was elevated
in the patients with PCO (11.3 ± 1.7 vs. 7.5 ± 1.2 μg per milliliter), but was not
significantly different. A positive correlation was found between LH levels and both
E2 and E1 concentrations in the patients with PCO. These data show a distinct profile of gonadotropin,
estrogen, and androgen levels in patients with PCO.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to American Journal of Obstetrics & GynecologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Fertil. Steril. 1970; 14: 1711
- J. Clin. Endocrinol. Metab. 1970; 30: 435
- J. Clin. Endocrinol. Metab. 1966; 26: 314
- J. Clin. Invest. 1967; 46: 891
- J. Clin. Endocrinol. Metab. 1968; 28: 479
- J. Clin. Endocrinol. Metab. 1969; 28: 1300
- J. Clin. Endocrinol. Metab. 1973; 37: 183
- J. Clin. Endocrinol. Metab. 1972; 34: 92
- Am. J. Obstet. Gynecol. 1967; 98: 687
- Recent Prog. Horm. Res. 1962; 18: 337
- Am. J. Obstet. Gynecol. 1969; 103: 555
- Anal. Biochem. 1963; 5: 422
- J. Clin. Endocrinol. Metab. 1968; 28: 1763
- J. Clin. Endocrinol. Metab. 1970; 30: 325
- J. Clin. Endocrinol. Metab. 1973; 36: 475
Hopper, B. R., and Yen, S. S. C.: J. Clin. Endocrinol. Metab. In press.
- J. Clin. Endocrinol. Metab. 1971; 33: 917
- Biochem. Med. 1970; 3: 365
- J. Clin. Endocrinol. Metab. 1973; 37: 356
- J. A. M. A. 1970; 211: 1513
- J. Clin. Endocrinol. Metab. 1969; 29: 149
- Am. J. Obstet. Gynecol. 1971; 111: 60
- J. Clin. Endocrinol. Metab. 1973; 37: 581
- J. Clin. Endocrinol. Metab. 1969; 29: 1433
- Handbook of Physiology—Endocrinology. Vol. II. American Physiological Society, Washington, D. C.,1973: 615 (Part I) ed. 3.
- J. Clin. Endocrinol. Metab. 1971; 33: 882
Article Info
Publication History
Accepted:
August 6,
1974
Received in revised form:
July 30,
1974
Received:
May 30,
1974
Footnotes
☆Supported by grant RF 70029 from the Rockefeller Foundation and by Agency for International Development grant CSD 2785.
Identification
Copyright
© 1975 Published by Elsevier Inc.